Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312]
Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus
Naproxen Sodium DS
Flanax Pain Relief Kit
PREVACID NapraPAC 375
Vimovo
Aleve-D Sinus and Cold
Aleve Back and Body Pain
Apo Naproxen Tab 125mg
Leader Naproxen Sodium
Naprosyn E Tab 250mg
Midol Extended Relief
All Day Relief
Nx 12 Hour
Naproxen Sodium and Diphenhydramine Hydrochloride
Sound Body Naproxen Sodium
Naprosyn
Fulton Street Market Naproxen Sodium
Naproxen Sodium Diphenhydramine HCL
Naproxen-375
Kirkland Signature Naproxen Sodium
Naprosyn Sup 500mg
Riva-naproxen
Humana Pharmacy All Day Pain Relief
Naproxen 125 Tab 125mg
Rx Act Naproxen Sodium
All Day Sinus and Cold D
Pain Relief All Day
Signature Care Pain Relief
Teva-naproxen
Medique Mediproxen
Napropak Cool
Rapidol Naproxen
Naproxen-NA DF
Naproxen Sodium and Diphenhydramine HCl
Pain Zero
All Day Pain Relief Naproxen Sodium
Teva-naproxen EC
Naproxen Sodium and Diphenhydramine HCL
Ntp-naproxen
Naproxen Kit
PMS-naproxen EC
Indication
Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682